Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
BlackRock, Inc.'s stake in Eledon Pharmaceuticals, Inc. fell to 4.60% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc.'s stake in Eledon Pharmaceuticals, Inc. fell to 4.60%, 3,625,824 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 3,625,824
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.60% | 3,625,824 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- BlackRock, Inc.
- Eledon Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026